ACT for ALS reauthorization push before September 2026 expiration
Federal lawmakers and ALS organizations are pushing to reauthorize ACT for ALS programs before current authorization expires on September 30, 2026.
Federal · Active · Implementation Sep 30, 2026
What it is
- What changed
- The ACT for ALS Reauthorization Act of 2026 was introduced to extend programs tied to expanded access, ALS research, rare neurodegenerative disease action planning, and reporting.
- Why it matters
- For ALS families, federal program continuity can affect treatment-access pathways, research infrastructure, and advocacy urgency before the September 2026 deadline.
- Who it touches
- Family caregivers, People receiving carepeople living with ALS, ALS caregivers, rare neurodegenerative disease families, research programs, expanded-access programs
- What it does
- Plans, studies, registries or guidance
Sources
- Calvert House release on ACT for ALS Reauthorization Act
- ACT for ALS Reauthorization draft text(tracker)
- ALS United action alert(advocacy)
Last reviewed Jun 18, 2026. This is information, not legal advice; check the source for the current text.